...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: THIS IS NEW ,,, What if
Thanks Stock. I think Fouremm's Newco Ownership thread is worth a re-read too. Let's hope we're right...there seems to be a lot of signals that we might be! Woo-hoo!! PVLee
Share
New Message
Please login to post a reply